Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failure.
Taylor CR, Baird JR, Blackburn KJ, Cambridge D, Constantine JW, Ghaly MS, Hayden ML, McIlhenny HM, Moore PF, Olukotun AY, Pullman LG, Salsburg DS, Saxton CA, Shevde S.
Taylor CR, et al. Among authors: moore pf.
Am Heart J. 1981 Sep;102(3 Pt 2):515-32. doi: 10.1016/0002-8703(81)90740-7.
Am Heart J. 1981.
PMID: 7023221
Review.
Early promise in CHF therapy is being shown by a novel series of cyclic adenosine monophosphate (cAMP) phosphodiesterase inhibitors with combined direct inotropic and vasodilator effects. Double-blind long-term studies demonstrate persistent efficacy of prazosin and trimaz …
Early promise in CHF therapy is being shown by a novel series of cyclic adenosine monophosphate (cAMP) phosphodiesterase inhibitors with com …